Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2012012667 - MÉTHODES ET COMPOSITIONS POUR MODIFIER UN LOCUS HLA

Numéro de publication WO/2012/012667
Date de publication 26.01.2012
N° de la demande internationale PCT/US2011/044902
Date du dépôt international 21.07.2011
CIB
C07K 14/00 2006.01
CCHIMIE; MÉTALLURGIE
07CHIMIE ORGANIQUE
KPEPTIDES
14Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés
CPC
A61K 35/17
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
14Blood; Artificial blood
17Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
A61P 17/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61P 17/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
06Antipsoriatics
A61P 19/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
A61P 19/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
A61P 19/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
04for non-specific disorders of the connective tissue
Déposants
  • SANGAMO BIOSCIENCES, INC. [US/US]; Point Richmond Tech Center 501 Canal Blvd., Suite A100 Richmond, California 94804, US (AllExceptUS)
  • BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM [US/US]; 1515 Holcombe Blvd. Houston, Texas 77030, US (AllExceptUS)
  • COLLINGWOOD, Trevor [NZ/US]; US (UsOnly)
  • COOPER, Laurence J.,N. [US/US]; US (UsOnly)
  • GREGORY, Philip D. [GB/US]; US (UsOnly)
  • HOLMES, Michael C. [US/US]; US (UsOnly)
  • MILLER, Jeffrey C. [US/US]; US (UsOnly)
  • REBAR, Edward J. [US/US]; US (UsOnly)
  • REIK, Andreas [DE/US]; US (UsOnly)
  • URNOV, Fyodor [US/US]; US (UsOnly)
Inventeurs
  • COLLINGWOOD, Trevor; US
  • COOPER, Laurence J.,N.; US
  • GREGORY, Philip D.; US
  • HOLMES, Michael C.; US
  • MILLER, Jeffrey C.; US
  • REBAR, Edward J.; US
  • REIK, Andreas; US
  • URNOV, Fyodor; US
Mandataires
  • PASTERNAK, Dahna, S.; Pasternak Patent Law 1900 Embarcadero Rd. Suite 211 Palo Alto, CA 94303, US
Données relatives à la priorité
61/400,00921.07.2010US
61/404,68506.10.2010US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) METHODS AND COMPOSITIONS FOR MODIFICATION OF A HLA LOCUS
(FR) MÉTHODES ET COMPOSITIONS POUR MODIFIER UN LOCUS HLA
Abrégé
(EN)
Disclosed herein are methods and compositions for modulating the expression of a HLA locus or for selectively deleting or manipulating a HLA locus or HLA regulator.
(FR)
L'invention concerne des méthodes et des compositions pour moduler l'expression d'un locus HLA ou encore pour supprimer ou manipuler sélectivement un locus HLA ou un régulateur de HLA.
Également publié en tant que
Dernières données bibliographiques dont dispose le Bureau international